News 2018-05-31T12:31:02+00:00

Latest News

April 16, 2018 – LimFlow raises €27M in Series C financing led by Sofinnova Partners.
MORE

February 6, 2018 – Nomination of Pierre Guyot as Chairman of Board of Directors and Expansion of Senior Management Team.
MORE

January 29, 2018 – US Feasibility Study Enrollment completion and Granting of the FDA Breakthrough Device Status.
MORE

August 1, 2017 – Publication of Positive Results from Pilot Study of LimFlow Percutaneous Deep Vein Arterialization (pDVA) System
MORE

July 11, 2017 – LimFlow Announces First Patient Treated in U.S. Feasibility Study and Commencement of International Post-Market Study
MORE

June 6, 2017 – LimFlow Expands Senior Management Team and Opens Silicon Valley Office
MORE

April 26, 2017 – LimFlow Receives FDA Approval for U.S. Feasibility Study of Minimally-Invasive Technology Designed to Restore Perfusion in “No Option” Critical Limb Ischemia Patients
MORE

November 15, 2016 – LimFlow Receives CE Mark for Purely Percutaneous Critical Limb Ischemia (CLI) Technology Designed to Restore Perfusion for “No Option” Patients
MORE

December 15, 2014 – LimFlow Announces Presentation of the LimFlow Procedure at a Dedicated Symposium During the Leipzig Interventional Course, LINC 2015
MORE

September 30, 2014 – LimFlow Announces the Closing of Series A Financing
MORE